C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target

E. Katz; D. Faratian; J. M. S. Bartlett; K. MacLeod; H. Pedersen; A. Larionov; E. M. Smith; A. P. Howell; J. M. Dixon; E. E. Evans; S. P. Langdon; D. J. Harrison

doi:10.1186/bcr1961

C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target

E. Katz, D. Faratian, J. M. S. Bartlett, K. MacLeod, H. Pedersen, A. Larionov, E. M. Smith, A. P. Howell, J. M. Dixon, E. E. Evans, S. P. Langdon, D. J. Harrison

School of Medicine

Research output: Contribution to journal › Abstract › peer-review

Original language	English
Article number	P77
Pages (from-to)	S39-S39
Number of pages	1
Journal	Breast Cancer Research
Volume	10
DOIs	https://doi.org/10.1186/bcr1961
Publication status	Published - 13 May 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1186/bcr1961

bcr1961
© 2008 BioMed Central Ltd
Final published version, 2.6 MB

Cite this

Katz, E., Faratian, D., Bartlett, J. M. S., MacLeod, K., Pedersen, H., Larionov, A., Smith, E. M., Howell, A. P., Dixon, J. M., Evans, E. E., Langdon, S. P., & Harrison, D. J. (2008). C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target. Breast Cancer Research, 10, S39-S39. Article P77. https://doi.org/10.1186/bcr1961

@article{642e98630bc04e88a69bd09661bb0d05,

title = "C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target",

author = "E. Katz and D. Faratian and Bartlett, \{J. M. S.\} and K. MacLeod and H. Pedersen and A. Larionov and Smith, \{E. M.\} and Howell, \{A. P.\} and Dixon, \{J. M.\} and Evans, \{E. E.\} and Langdon, \{S. P.\} and Harrison, \{D. J.\}",

year = "2008",

month = may,

day = "13",

doi = "10.1186/bcr1961",

language = "English",

volume = "10",

pages = "S39--S39",

journal = "Breast Cancer Research",

issn = "1465-5411",

publisher = "BioMed Central",

}

Katz, E, Faratian, D, Bartlett, JMS, MacLeod, K, Pedersen, H, Larionov, A, Smith, EM, Howell, AP, Dixon, JM, Evans, EE, Langdon, SP & Harrison, DJ 2008, 'C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target', Breast Cancer Research, vol. 10, P77, pp. S39-S39. https://doi.org/10.1186/bcr1961

TY - JOUR

T1 - C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target

AU - Katz, E.

AU - Faratian, D.

AU - Bartlett, J. M. S.

AU - MacLeod, K.

AU - Pedersen, H.

AU - Larionov, A.

AU - Smith, E. M.

AU - Howell, A. P.

AU - Dixon, J. M.

AU - Evans, E. E.

AU - Langdon, S. P.

AU - Harrison, D. J.

PY - 2008/5/13

Y1 - 2008/5/13

U2 - 10.1186/bcr1961

DO - 10.1186/bcr1961

M3 - Abstract

SN - 1465-5411

VL - 10

SP - S39-S39

JO - Breast Cancer Research

JF - Breast Cancer Research

M1 - P77

ER -